Report Detail

Request for Sample of this report

Service & Software Global Intermediate CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4509619
    • |
  • 13 February, 2023
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Intermediate CDMO market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Intermediate CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intermediate CDMO market size and forecasts, in consumption value ($ Million), 2018-2029
Global Intermediate CDMO market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Intermediate CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Intermediate CDMO market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intermediate CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intermediate CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pharmira, AGC Inc, Blue Jet Healthcare, Drug Discovery Alliances and KriSan Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Intermediate CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antibiotic Intermediates
Antipyretic and Analgesic Intermediate
Cardiovascular System Drug Intermediates
Anticancer Drug Intermediates
Market segment by Application
Pharmaceutical Company
Biotechnology Company
Generic Company
Others
Market segment by players, this report covers
Pharmira
AGC Inc
Blue Jet Healthcare
Drug Discovery Alliances
KriSan Biotech
Saurav Chemicals
Olon SpA
AGC Biologics
Fermion
Pfizer CentreOne
Aspen Holdings
Educell
Hovione
Porton Pharma Solutions
Sinopep
Chongqing Huapont Pharmaceutical
Langhua Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Intermediate CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Intermediate CDMO, with revenue, gross margin and global market share of Intermediate CDMO from 2018 to 2023.
Chapter 3, the Intermediate CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Intermediate CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Intermediate CDMO.
Chapter 13, to describe Intermediate CDMO research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Intermediate CDMO
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Intermediate CDMO by Type
    • 1.3.1 Overview: Global Intermediate CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Intermediate CDMO Consumption Value Market Share by Type in 2022
    • 1.3.3 Antibiotic Intermediates
    • 1.3.4 Antipyretic and Analgesic Intermediate
    • 1.3.5 Cardiovascular System Drug Intermediates
    • 1.3.6 Anticancer Drug Intermediates
  • 1.4 Global Intermediate CDMO Market by Application
    • 1.4.1 Overview: Global Intermediate CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Pharmaceutical Company
    • 1.4.3 Biotechnology Company
    • 1.4.4 Generic Company
    • 1.4.5 Others
  • 1.5 Global Intermediate CDMO Market Size & Forecast
  • 1.6 Global Intermediate CDMO Market Size and Forecast by Region
    • 1.6.1 Global Intermediate CDMO Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Intermediate CDMO Market Size by Region, (2018-2029)
    • 1.6.3 North America Intermediate CDMO Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Intermediate CDMO Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Intermediate CDMO Market Size and Prospect (2018-2029)
    • 1.6.6 South America Intermediate CDMO Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Intermediate CDMO Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Pharmira
    • 2.1.1 Pharmira Details
    • 2.1.2 Pharmira Major Business
    • 2.1.3 Pharmira Intermediate CDMO Product and Solutions
    • 2.1.4 Pharmira Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Pharmira Recent Developments and Future Plans
  • 2.2 AGC Inc
    • 2.2.1 AGC Inc Details
    • 2.2.2 AGC Inc Major Business
    • 2.2.3 AGC Inc Intermediate CDMO Product and Solutions
    • 2.2.4 AGC Inc Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 AGC Inc Recent Developments and Future Plans
  • 2.3 Blue Jet Healthcare
    • 2.3.1 Blue Jet Healthcare Details
    • 2.3.2 Blue Jet Healthcare Major Business
    • 2.3.3 Blue Jet Healthcare Intermediate CDMO Product and Solutions
    • 2.3.4 Blue Jet Healthcare Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Blue Jet Healthcare Recent Developments and Future Plans
  • 2.4 Drug Discovery Alliances
    • 2.4.1 Drug Discovery Alliances Details
    • 2.4.2 Drug Discovery Alliances Major Business
    • 2.4.3 Drug Discovery Alliances Intermediate CDMO Product and Solutions
    • 2.4.4 Drug Discovery Alliances Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Drug Discovery Alliances Recent Developments and Future Plans
  • 2.5 KriSan Biotech
    • 2.5.1 KriSan Biotech Details
    • 2.5.2 KriSan Biotech Major Business
    • 2.5.3 KriSan Biotech Intermediate CDMO Product and Solutions
    • 2.5.4 KriSan Biotech Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 KriSan Biotech Recent Developments and Future Plans
  • 2.6 Saurav Chemicals
    • 2.6.1 Saurav Chemicals Details
    • 2.6.2 Saurav Chemicals Major Business
    • 2.6.3 Saurav Chemicals Intermediate CDMO Product and Solutions
    • 2.6.4 Saurav Chemicals Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Saurav Chemicals Recent Developments and Future Plans
  • 2.7 Olon SpA
    • 2.7.1 Olon SpA Details
    • 2.7.2 Olon SpA Major Business
    • 2.7.3 Olon SpA Intermediate CDMO Product and Solutions
    • 2.7.4 Olon SpA Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Olon SpA Recent Developments and Future Plans
  • 2.8 AGC Biologics
    • 2.8.1 AGC Biologics Details
    • 2.8.2 AGC Biologics Major Business
    • 2.8.3 AGC Biologics Intermediate CDMO Product and Solutions
    • 2.8.4 AGC Biologics Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 AGC Biologics Recent Developments and Future Plans
  • 2.9 Fermion
    • 2.9.1 Fermion Details
    • 2.9.2 Fermion Major Business
    • 2.9.3 Fermion Intermediate CDMO Product and Solutions
    • 2.9.4 Fermion Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Fermion Recent Developments and Future Plans
  • 2.10 Pfizer CentreOne
    • 2.10.1 Pfizer CentreOne Details
    • 2.10.2 Pfizer CentreOne Major Business
    • 2.10.3 Pfizer CentreOne Intermediate CDMO Product and Solutions
    • 2.10.4 Pfizer CentreOne Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Pfizer CentreOne Recent Developments and Future Plans
  • 2.11 Aspen Holdings
    • 2.11.1 Aspen Holdings Details
    • 2.11.2 Aspen Holdings Major Business
    • 2.11.3 Aspen Holdings Intermediate CDMO Product and Solutions
    • 2.11.4 Aspen Holdings Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Aspen Holdings Recent Developments and Future Plans
  • 2.12 Educell
    • 2.12.1 Educell Details
    • 2.12.2 Educell Major Business
    • 2.12.3 Educell Intermediate CDMO Product and Solutions
    • 2.12.4 Educell Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Educell Recent Developments and Future Plans
  • 2.13 Hovione
    • 2.13.1 Hovione Details
    • 2.13.2 Hovione Major Business
    • 2.13.3 Hovione Intermediate CDMO Product and Solutions
    • 2.13.4 Hovione Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Hovione Recent Developments and Future Plans
  • 2.14 Porton Pharma Solutions
    • 2.14.1 Porton Pharma Solutions Details
    • 2.14.2 Porton Pharma Solutions Major Business
    • 2.14.3 Porton Pharma Solutions Intermediate CDMO Product and Solutions
    • 2.14.4 Porton Pharma Solutions Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Porton Pharma Solutions Recent Developments and Future Plans
  • 2.15 Sinopep
    • 2.15.1 Sinopep Details
    • 2.15.2 Sinopep Major Business
    • 2.15.3 Sinopep Intermediate CDMO Product and Solutions
    • 2.15.4 Sinopep Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Sinopep Recent Developments and Future Plans
  • 2.16 Chongqing Huapont Pharmaceutical
    • 2.16.1 Chongqing Huapont Pharmaceutical Details
    • 2.16.2 Chongqing Huapont Pharmaceutical Major Business
    • 2.16.3 Chongqing Huapont Pharmaceutical Intermediate CDMO Product and Solutions
    • 2.16.4 Chongqing Huapont Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Chongqing Huapont Pharmaceutical Recent Developments and Future Plans
  • 2.17 Langhua Pharmaceutical
    • 2.17.1 Langhua Pharmaceutical Details
    • 2.17.2 Langhua Pharmaceutical Major Business
    • 2.17.3 Langhua Pharmaceutical Intermediate CDMO Product and Solutions
    • 2.17.4 Langhua Pharmaceutical Intermediate CDMO Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Langhua Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Intermediate CDMO Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Intermediate CDMO by Company Revenue
    • 3.2.2 Top 3 Intermediate CDMO Players Market Share in 2022
    • 3.2.3 Top 6 Intermediate CDMO Players Market Share in 2022
  • 3.3 Intermediate CDMO Market: Overall Company Footprint Analysis
    • 3.3.1 Intermediate CDMO Market: Region Footprint
    • 3.3.2 Intermediate CDMO Market: Company Product Type Footprint
    • 3.3.3 Intermediate CDMO Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Intermediate CDMO Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Intermediate CDMO Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Intermediate CDMO Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Intermediate CDMO Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Intermediate CDMO Consumption Value by Type (2018-2029)
  • 6.2 North America Intermediate CDMO Consumption Value by Application (2018-2029)
  • 6.3 North America Intermediate CDMO Market Size by Country
    • 6.3.1 North America Intermediate CDMO Consumption Value by Country (2018-2029)
    • 6.3.2 United States Intermediate CDMO Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Intermediate CDMO Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Intermediate CDMO Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Intermediate CDMO Consumption Value by Type (2018-2029)
  • 7.2 Europe Intermediate CDMO Consumption Value by Application (2018-2029)
  • 7.3 Europe Intermediate CDMO Market Size by Country
    • 7.3.1 Europe Intermediate CDMO Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Intermediate CDMO Market Size and Forecast (2018-2029)
    • 7.3.3 France Intermediate CDMO Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Intermediate CDMO Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Intermediate CDMO Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Intermediate CDMO Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Intermediate CDMO Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Intermediate CDMO Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Intermediate CDMO Market Size by Region
    • 8.3.1 Asia-Pacific Intermediate CDMO Consumption Value by Region (2018-2029)
    • 8.3.2 China Intermediate CDMO Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Intermediate CDMO Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Intermediate CDMO Market Size and Forecast (2018-2029)
    • 8.3.5 India Intermediate CDMO Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Intermediate CDMO Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Intermediate CDMO Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Intermediate CDMO Consumption Value by Type (2018-2029)
  • 9.2 South America Intermediate CDMO Consumption Value by Application (2018-2029)
  • 9.3 South America Intermediate CDMO Market Size by Country
    • 9.3.1 South America Intermediate CDMO Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Intermediate CDMO Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Intermediate CDMO Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Intermediate CDMO Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Intermediate CDMO Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Intermediate CDMO Market Size by Country
    • 10.3.1 Middle East & Africa Intermediate CDMO Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Intermediate CDMO Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Intermediate CDMO Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Intermediate CDMO Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Intermediate CDMO Market Drivers
  • 11.2 Intermediate CDMO Market Restraints
  • 11.3 Intermediate CDMO Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Intermediate CDMO Industry Chain
  • 12.2 Intermediate CDMO Upstream Analysis
  • 12.3 Intermediate CDMO Midstream Analysis
  • 12.4 Intermediate CDMO Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Intermediate CDMO. Industry analysis & Market Report on Intermediate CDMO is a syndicated market report, published as Global Intermediate CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Intermediate CDMO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,770.08
    		4,155.12
    		5,540.16
    		3,232.92
    		4,849.38
    		6,465.84
    		535,711.20
    		803,566.80
    		1,071,422.40
    		290,614.80
    		435,922.20
    		581,229.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo